About VCRO
VCRO Overview
Get to know us better
Chronicles
Professional Team
Shanghai VCRO
USA VCRO
Services
Medical Affairs
Explore what we offer
Clinical Operations
Project Management
Data Management & Biometrics
GCP Inspection
Business Development
E-tools Service
News
VCRO news
Keep up with
VCRO
Industry News
Careers
Contact us
Contact form
Let’s get in touch
Location
English
/
繁中版
/
简中版
Contact us
Home
/
News
In
VCRO express
VCRO express
Congratulations! A Phase III IND application for Neurology multinational study was granted by TFDA!
•
Nov 19
VCRO express
Congratulation! A radiocontrast agent drug was granted by the US FDA!
•
Oct 5
VCRO express
VCRO participates in 2020 TMUxBE Demo Day
•
Aug 11
VCRO express
Congratulations! VCRO Complete SaMD Clinical Trial at US
•
May 29
VCRO express
Congratulation! An 505b2 drug for pain control was granted by the US FDA!
•
Apr 8
VCRO express
Congratulation! An 505b1 drug for treating cardiovascular was granted by the US FDA!
•
Jan 30
VCRO express
Congratulations! VCRO obtained a clinical-go from the US FDA to launch the Phase I/IIa clinical trial of a botanic drugs!
•
Oct 3
VCRO express
VCRO meet-up: FDA IND submission in cell therapy
•
Sep 25
VCRO express
Congratulations! Approval was granted by TFDA for a phase II cell therapy clinical trial study
•
Sep 12
VCRO express
Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA
•
Sep 3
1
2
3
4
5
6
Previous Page
Next Page
Scroll Up
